Literature DB >> 35030567

Capitalizing on Central Registries for Expanded Cancer Surveillance and Research.

Cathy J Bradley1,2, Julia Entwistle2, Lindsay M Sabik3, Richard C Lindrooth2, Marcelo Perraillon1,2.   

Abstract

BACKGROUND: State central cancer registries are an essential component of cancer surveillance and research that can be enriched through linkages to other databases. This study identified and described state central registry linkages to external data sources and assessed the potential for a more comprehensive data infrastructure with registries at its core.
METHODS: We identified peer-reviewed papers describing linkages to state central cancer registries in all 50 states, Washington, DC, and Puerto Rico, published between 2010 and 2020. To complement the literature review, we surveyed registrars to learn about unpublished linkages. Linkages were grouped by medical claims (public and private insurers), medical records, other registries (eg, human immunodeficiency virus/acquired immunodeficiency syndrome registries, birth certificates, screening programs), and data from specific cohorts (eg, firefighters, teachers).
RESULTS: We identified 464 data linkages with state central cancer registries. Linkages to cohorts and other registries were most common. Registries in predominately rural states reported the fewest linkages. Most linkages are not ongoing, maintained, or available to researchers. A third of linkages reported by registrars did not result in published papers.
CONCLUSIONS: Central cancer registries, often in collaboration with researchers, have enriched their data through linkages. These linkages demonstrate registries' ability to contribute to a data infrastructure, but a coordinated and maintained approach is needed to leverage these data for research. Sparsely populated states reported the fewest linkages, suggesting possible gaps in our knowledge about cancer in these states. Many more linkages exist than have been reported in the literature, highlighting potential opportunities to further use the data for research purposes.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35030567      PMCID: PMC8820319          DOI: 10.1097/MLR.0000000000001675

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  12 in total

1.  Rural-Urban Differences in Cancer Incidence and Trends in the United States.

Authors:  Whitney E Zahnd; Aimee S James; Wiley D Jenkins; Sonya R Izadi; Amanda J Fogleman; David E Steward; Graham A Colditz; Laurent Brard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-27       Impact factor: 4.254

2.  Disparities in Cancer Incidence and Trends among American Indians and Alaska Natives in the United States, 2010-2015.

Authors:  Stephanie C Melkonian; Melissa A Jim; Donald Haverkamp; Charles L Wiggins; Jeffrey McCollum; Mary C White; Judith S Kaur; David K Espey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

Review 3.  State-level cancer quality assessment and research: building and sustaining the data infrastructure.

Authors:  Joseph Lipscomb; Theresa W Gillespie
Journal:  Cancer J       Date:  2011 Jul-Aug       Impact factor: 3.360

4.  The added value of claims for cancer surveillance: results of varying case definitions.

Authors:  Lynne Penberthy; Donna McClish; Claudine Manning; Sheldon Retchin; Tom Smith
Journal:  Med Care       Date:  2005-07       Impact factor: 2.983

5.  Four health data networks illustrate the potential for a shared national multipurpose big-data network.

Authors:  Lesley H Curtis; Jeffrey Brown; Richard Platt
Journal:  Health Aff (Millwood)       Date:  2014-07       Impact factor: 6.301

6.  Health Insurance Coverage Disruptions and Cancer Care and Outcomes: Systematic Review of Published Research.

Authors:  K Robin Yabroff; Katherine Reeder-Hayes; Jingxuan Zhao; Michael T Halpern; Ana Maria Lopez; Leon Bernal-Mizrachi; Anderson B Collier; Joan Neuner; Jonathan Phillips; William Blackstock; Manali Patel
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

7.  Feasibility of Capturing Cancer Treatment Data in the Utah All-Payer Claims Database.

Authors:  Mia Hashibe; Judy Y Ou; Kimberly Herget; Dan Bolton; Jordan McPherson; Charles Hawley; Jennifer Garvin; Jennifer A Doherty; Carol Sweeney
Journal:  JCO Clin Cancer Inform       Date:  2019-10

8.  Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births.

Authors:  Philip J Lupo; Jeremy M Schraw; Tania A Desrosiers; Wendy N Nembhard; Peter H Langlois; Mark A Canfield; Glenn Copeland; Robert E Meyer; Austin L Brown; Tiffany M Chambers; Pagna Sok; Heather E Danysh; Susan E Carozza; Saumya D Sisoudiya; Susan G Hilsenbeck; Amanda E Janitz; Matthew E Oster; Angela E Scheuerle; Joshua D Schiffman; Chunqiao Luo; Amir Mian; Beth A Mueller; Chad D Huff; Sonja A Rasmussen; Michael E Scheurer; Sharon E Plon
Journal:  JAMA Oncol       Date:  2019-08-01       Impact factor: 31.777

9.  Innovative Solutions for State Medicaid Programs to Leverage Their Data, Build Their Analytic Capacity, and Create Evidence-Based Policy.

Authors:  Lauren Adams; Susan Kennedy; Lindsay Allen; Andrew Barnes; Tom Bias; Dushka Crane; Paul Lanier; Rachel Mauk; Shamis Mohamoud; Nathan Pauly; Jeffrey Talbert; Cynthia Woodcock; Kara Zivin; Julie Donohue
Journal:  EGEMS (Wash DC)       Date:  2019-08-05

10.  Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research.

Authors:  Allison W Kurian; Aya Mitani; Manisha Desai; Peter P Yu; Tina Seto; Susan C Weber; Cliff Olson; Pragati Kenkare; Scarlett L Gomez; Monique A de Bruin; Kathleen Horst; Jeffrey Belkora; Suepattra G May; Dominick L Frosch; Douglas W Blayney; Harold S Luft; Amar K Das
Journal:  Cancer       Date:  2013-09-24       Impact factor: 6.921

View more
  1 in total

1.  Policies and Practices to Address Cancer's Long-Term Adverse Consequences.

Authors:  Cathy J Bradley; Sara Kitchen; Smita Bhatia; Julie Bynum; Gwen Darien; J Leonard Lichtenfeld; Randall Oyer; Lawrence N Shulman; Lisa Kennedy Sheldon
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.